Ju-Hyun Bae

Mr. Ju-Hyun Bae

Kyungpook National University, Daegu, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ECEun-Ji Choe
Eun-Ji Choe
CLChan-Hyeong Lee
Chan-Hyeong Lee
JBJu-Hyun Bae
Ju-Hyun Bae
PJPark Jumi
Park Jumi
SPSeong-Sik Park
Seong-Sik Park
MBMoon-Chang Baek
Moon-Chang Baek
According to clinical studies, statins improve the efficacy of programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) blockade therapy for breast cancer; however, the underlying mechanisms are unclear. Herein, we showed that atorvastatin (ATO) decreased the content of PD-L1 in extracellular vesicles (EVs) by reducing cellular PD-L1 expression and inhibiting EV secretion in breast cancer cells, thereby enhancing the efficacy of anti-PD-L1 therapy. ATO reduced EV secretion by regulating the Rab proteins involved in EV biogenesis and secretion. ATO-mediated inhibition of the Ras-activated MAPK signaling pathway downregulated PD-L1 expression. In addition, ATO strongly promoted antitumor efficacy by inducing T cell-mediated tumor destruction when combined with an anti-PD-L1 antibody. Moreover, suppression of EV PD-L1 by ATO improved the reactivity of anti-PD-L1 therapy by enhancing T-cell activity in draining lymph nodes of EMT6-bearing immunocompetent mice. Therefore, ATO is a potential therapeutic drug that improves antitumor immunity by inhibiting EV PD-L1, particularly in response to immune escape during cancer.

Verified
Journal Article
Open access
PDF file
JEJung-Young Eom
Jung-Young Eom
SCSang-Hun Choi
Sang-Hun Choi
HKHyun-Jin Kim
Hyun-Jin Kim
DKDong-Ha Kim
Dong-Ha Kim
JBJu-Hyun Bae
Ju-Hyun Bae
Young-Eun ChoYoung-Eun Cho
Young-Eun Cho
Hemp (Cannabis sativa L.) is used for medicinal purposes owing to its anti-inflammatory and antioxidant activities. We evaluated the protective effect of nanovesicles isolated from hemp plant parts (root, seed, hemp sprout, and leaf) in dextran sulfate sodium (DSS)-induced colitis in mice. The particle sizes of root-derived nanovesicles (RNVs), seed-derived nanovesicles (SNVs), hemp sprout-derived nanovesicles (HSNVs), and leaf-derived nanovesicles (LNVs) were within the range of 100–200 nm as measured by nanoparticle tracking analysis. Acute colitis was induced in C57BL/N mice by 5% DSS in water provided for 7 days. RNVs were administered orally once a day, leading to the recovery of both the small intestine and colon lengths. RNVs, SNVs, and HSNVs restored the tight (ZO-1, claudin-4, occludin) and adherent junctions (E-cadherin and α-tubulin) in DSS-induced small intestine and colon injury. Additionally, RNVs markedly reduced NF-κB activation and oxidative stress proteins in DSS-induced small intestine and colon injury. Tight junction protein expression and epithelial cell permeability were elevated in RNV-, SNV-, and HSNV-treated T84 colon cells exposed to 2% DSS. Interestedly, RNVs, SNVs, HSNVs, and LNVs reduced ALT activity and liver regeneration marker proteins in DSS-induced liver injury. These results showed for the first time that hemp-derived nanovesicles (HNVs) exhibited a protective effect on DSS-induced gut leaky and liver injury through the gut–liver axis by inhibiting oxidative stress marker proteins.

23 August 2022 in Cancers
Verified
Journal Article
Open access
PDF file
SPSeong-Sik Park
Seong-Sik Park
JKJong-In Kim
Jong-In Kim
CLChan-Hyeong Lee
Chan-Hyeong Lee
JBJu-Hyun Bae
Ju-Hyun Bae
JPJu-Mi Park
Ju-Mi Park
MBMoon-Chang Baek
Moon-Chang Baek
Tumor-derived small extracellular vesicle (sEV) programmed death-ligand 1 (PD-L1) contributes to the low reactivity of cells to immune checkpoint blockade therapy (ICBT), because sEV PD-L1 binds to programmed death 1 (PD-1) in immune cells. However, there are no commercially available anti-cancer drugs that activate immune cells by inhibiting tumor-derived sEV PD-L1 secretion and cellular PD-L1. Here, we aimed to investigate if temsirolimus (TEM) inhibits both sEV PD-L1 and cellular PD-L1 levels in MDA-MB-231 cells. In cancer cell autophagy activated by TEM, multivesicular bodies (MVBs) associated with the secretion of sEV are degraded through colocalization with autophagosomes or lysosomes. TEM promotes CD8+ T cell-mediated anti-cancer immunity in co-cultures of CD8+ T cells and tumor cells. Furthermore, the combination therapy of TEM and anti-PD-L1 antibodies enhanced anti-cancer immunity by increasing both the number and activity of CD4+ and CD8+ T cells in the tumor and draining lymph nodes (DLNs) of breast cancer-bearing immunocompetent mice. In contrast, the anti-cancer effect of the combination therapy with TEM and anti-PD-L1 antibodies was reversed by the injection of exogenous sEV PD-L1. These findings suggest that TEM, previously known as a targeted anti-cancer drug, can overcome the low reactivity of ICBT by inhibiting sEV PD-L1 and cellular PD-L1 levels.

18 October 2024 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
MPMinsu Park
Minsu Park
CLChan-Hyeong Lee
Chan-Hyeong Lee
HNHyowoong Noh
Hyowoong Noh
GKGeeyoon Kang
Geeyoon Kang
JLJunyeong Lee
Junyeong Lee
HPHongsik Park
Hongsik Park

17 October 2026 in Bioactive Materials
Verified
Journal Article
Open access
DJDokyung Jung
Dokyung Jung
JBJu-Hyun Bae
Ju-Hyun Bae
IJIl-Young Jung
Il-Young Jung
NKNa-Eun Kim
Na-Eun Kim
JSJung Min Sung
Jung Min Sung
MBMoon-Chang Baek
Moon-Chang Baek
Plant-derived nanoparticles (PNPs) have emerged as a promising class of bioactive nanomaterials with intrinsic immunomodulatory properties, offering a sustainable and biocompatible alternative to synthetic delivery systems. However, their systematic exploration has been hindered by a fragmented “one-plant-one-function” research paradigm. Here, we establish a comprehensive bio-discovery platform by constructing a taxonomically diverse library of 110 PNPs. Through integrated physicochemical characterization and high-throughput functional screening, we identify Allium tuberosum-derived nanoparticles (ANPs) as a potent bioactive nanoparticle that effectively promotes pro-inflammatory macrophage polarization. Mechanistically, we demonstrate that the bioactivity of ANPs is largely mediated by their endogenous RNA cargo, specifically ANP-miR-488, which modulates the Bcl6 signaling axis to initiate macrophage reprogramming. Furthermore, ANPs significantly sensitize cold tumors to immune checkpoint blockade therapy in a syngeneic LLC1 lung carcinoma model. This study not only provides a generalizable strategy for the systematic discovery of bioactive nanomaterials but also highlights the clinical potential of RNA-mediated PNPs as a promising platform for enhancing cancer immunotherapy.

29 January 2026 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
MPMinsu Park
Minsu Park
GKGeeyoon Kang
Geeyoon Kang
JKJinseock Kong
Jinseock Kong
HMHyeri Moon
Hyeri Moon
JLJunyeong Lee
Junyeong Lee
HPHongsik Park
Hongsik Park